Cholesterol: until which age 'the lower the better'?

Submitted: June 9, 2016
Accepted: June 9, 2016
Published: June 22, 2016
Abstract Views: 1523
PDF: 871
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

In the elderly and particularly in the very elderly the prognostic role of hypercholesterolemia is uncertain and there are conflicting data from the literature. In some studies, the relation between high levels of cholesterol and cardiovascular events, strongly demonstrated for younger subjects, has been confirmed also in the elderly, conversely in other studies a relation between low cholesterol levels and higher mortality risk has been described, particularly in the very elderly. Furthermore, uncertainties regarding hypercholesterolemia treatment have been raised both in secondary and particularly in the primary prevention setting, because elderly subjects and particularly the very elderly have been excluded from randomized clinical trials. In this article the prognostic role of hypercholerlemia and its reduction in the elderly patients both in primary and secondary prevention settings are assessed.  

Riassunto

Nella popolazione anziana e soprattutto in quella molto anziana il ruolo prognostico dell’ipercolesterolemia non è così chiaro e i dati della letteratura sono contraddittori. Se infatti in alcuni studi è stata confermata l’associazione con eventi cardiovascolari, ampiamente descritta per soggetti più giovani, altri studi hanno messo in evidenza, soprattutto per i soggetti più anziani, un’associazione fra bassi livelli di colesterolo e mortalità. Vi sono anche incertezze relative all’effetto prognostico del trattamento dell’ipercolesterolemia sia in prevenzione secondaria che, soprattutto in prevenzione primaria poiché pazienti anziani e molto anziani sono stati frequentemente esclusi dai trial clinici. In questo articolo vengono quindi discusse le evidenze sul ruolo prognostico dell’ipercolesterolemia e sull’effetto prognostico della sua riduzione sia in ambito di prevenzione primaria che secondaria nel paziente anziano e molto anziano.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

How to Cite

Marchionni, Niccolò, and Francesco Orso. 2016. “Cholesterol: Until Which Age ’the Lower the better’?”. Monaldi Archives for Chest Disease 84 (1-2). https://doi.org/10.4081/monaldi.2015.749.

Similar Articles

<< < 3 4 5 6 7 8 9 10 11 12 > >> 

You may also start an advanced similarity search for this article.